CTRI/2019/10/021656尚未招募未知
Immunotherapy with purified protein derivative(PPD)in the management of chronic,recurrent or relapsing dermatophytosis: A,hospital based,interventional ,randomised,double blind comparative,study
GCS Medical college0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of either sex, aged more than 18 years ,suffering from chronic and relapsing dermatophytosis,confirmed by positive 10% potassium hydroxide mount for fungal hyphae
排除标准
- •1.Pregnant and lactating females
- •2.Patients with liver or renal failure or any malignancy
- •3.Patients with primary or acquired immunodeficiency
- •4.Patients with any major medical illness or surgical intervention within the preceding 4 weeks
- •5.Patients on concomitant medications which can interfere with immune response(eg steroids,immunosuppressants,chemotherapeutic agents)
- •6.Patients with a past history of tuberculosis
研究者
相似试验
尚未招募
不适用
A clinical trial to Compare effects of purified protein derivative injection with liquid nitrogen spray for treatment of viralwartsCTRI/2015/03/005614StJOHN S medical college70
进行中（未招募）
不适用
Inmunoterapia con extracto alergénico despigmentado y polimerizado con glutaraldehído de Phleum pratense, en pacientes afectos de rinoconjuntivitis y/o asma alérgicosRinoconjuntivitis y asma por hipersensibilidad frente al polen de Phleum pratense.EUCTR2006-001437-18-ESaboratorios LETI, S.L. Unipersonal
招募中
1 期
Intravenous immunoglobulin rich in neutralising antibodies to SARS-CoV-2 (COVID-19) as a passive immunity modality in healthy individuals: an open-label, active control Phase 1/2 StudyACTRN12620001249943Aegros Ltd.30
招募中
1 期
Immunotherapy using WT1 peptide with surgical treatment, irradiation therapy, and Temozolomide administration against glioblastoma multiforme: A phase I/II study.glioblastoma multiformeJPRN-UMIN000002419Cancer Vaccination Therapy Research Network, Department of Immunology, Kochi Medical School45
招募中
不适用
Immunization with peptide-mix and adjuvant. A vaccine to induce cellular immunity against HIV-1 [retrospectively registered]HIV/AIDSPACTR201110000274327Statens Serum Institut (Helle Bossen Konradsen)20